4X4 MEDICINE AS: årsregnskap 2024 vs 2023
Grew 41% on revenue, stronger earnings
registry 2025-02-22; journal 2025 313074
Summary
What changed
Comparing Årsregnskap 2024 with 2023 for 4X4 MEDICINE AS. Revenue 679.3k NOK → 955.6k NOK (+40.7%). Net result +171.8k NOK → +280.9k NOK. Equity 782.4k NOK → 63.3k NOK.
On the constructive side: revenue rose; operating result improved; net result improved. Pressures included: equity eroded.
Also worth watching: thin equity buffer; cogs moved; book investments changed. All figures are taken from the published annual accounts for 4X4 MEDICINE AS.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from 679.3k NOK to 955.6k NOK (+40.7% YoY). Calculated
-
↑
Operating result improved
Operating result +201.6k NOK → +563.9k NOK (op. margin 29.7% → 59.0%). Calculated
-
↑
Net result improved
Net result +171.8k NOK → +280.9k NOK (net margin 25.3% → 29.4%). Calculated
-
↑
Cash rose
Bank deposits 1.13m NOK → 5.09m NOK (+350.3% YoY). Calculated
What deteriorated
-
↓
Equity eroded
Book equity 782.4k NOK → 63.3k NOK (equity ratio 53.0% → 1.2%). Calculated
Things to notice
-
·
Thin equity buffer
Equity ratio is 1.2% of assets — limited loss-absorbing capacity on a stand-alone basis. Interpretation
-
·
COGS moved
COGS / varekostnad 0 NOK → 37.6k NOK (None YoY). Calculated
-
·
Book investments changed
Investment / intangible book value 291.7k NOK → 97.2k NOK. Reported fact